When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Novo Nordisk (NOVO) is petitioning the FDA to exclude its diabetes drug liraglutide, also known as Victoza, from a list of ...

Right now, Novo stock is trading at a forward price-to-earnings (P/E) multiple of 22.5 -- its lowest level in well over a year. I think now is a terrific opportunity to scoop up shares of Novo on the ...

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

TJ Bio has reportedly submitted a biologics license application (BLA) to China’s Center for Drug Evaluation for GX-H9 ...

We recently compiled a list of the 13 Best Pharma Dividend Stocks To Buy In 2024. In this article, we are going to take a ...

The pharmaceutical industry in 2024 faced a relatively quiet year, with deal volumes similar to 2023 but lower deal values, ...

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

INR:3284. rummy wheels 2 Pharmaceutical companies cancel their drug production licenses Novo Nordisk's Sogroya gets FDA approval: first growth hormone for once-weekl ...

This policy may affect all machinery companies Novo Nordisk's Sogroya gets FDA approval: first growth hormone for once-weekly subcutaneous injection ORR up to 59%! Phase Ib trial data of PD-1 antibody ...

INR:4030. rummy today app These drugs are no longer sold in hospitals (list attached) Novo Nordisk's Sogroya gets FDA approval: first growth hormone for once-week ...